Encouraged by the aforementioned results, we investigated the therapeutic potential of PLOD3 knockdown on the initiation of CRC by employing a mouse model of colitis-associated tumorigenesis induced by AOM/DSS. Here, PLOD3 is linked to colorectal carcinoma.